Roles of PAD4 and netosis in experimental atherosclerosis and arterial injury implications for superfcial erosion

Circulation Research

Volumn 123, Issue 1, 2018, Pages 33-42

  Franck, Grégory ^a,b   Mawson, Thomas L ^a   Folco, Eduardo J ^a   Molinaro, Roberto ^a   Ruvkun, Victoria ^a   Engelbertsen, Daniel ^a   Liu, Xin ^a   Tesmenitsky, Yevgenia ^a   Shvartz, Eugenia ^a   Sukhova, Galina K ^a   Michel, Jean Baptiste ^b   Nicoletti, Antonino ^b   Lichtman, Andrew ^a   Wagner, Denisa ^c   Croce, Kevin J ^a   Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Acute coronary syndrome; Atherosclerosis; Endothelial cells; Granulocytes; Thrombosis

Indexed keywords

ARGININE DEIMINASE; DEOXYRIBONUCLEASE I; PEPTIDYL ARGININE DEIMINASE 4; UNCLASSIFIED DRUG; HYDROLASE; PEPTIDYLARGININE DEIMINASE 4, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTICLE; ATHEROGENESIS; ATHEROMA; BONE MARROW CELL; BONE MARROW DISEASE; CELL DEATH; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPERIMENTAL ATHEROSCLEROSIS; EXTRACELLULAR TRAP; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE; ANIMAL; ATHEROSCLEROTIC PLAQUE; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CAROTID ARTERY DISEASE; DRUG EFFECT; INJURY; INTIMA; OSTEOMYELITIS; PATHOLOGY; PHYSIOLOGY; THROMBOSIS;

ANIMALS; BONE MARROW TRANSPLANTATION; CAROTID ARTERY DISEASES; CELL DEATH; DEOXYRIBONUCLEASE I; EXTRACELLULAR TRAPS; HUMANS; HYDROLASES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; OSTEOMYELITIS; PLAQUE, ATHEROSCLEROTIC; THROMBOSIS; TUNICA INTIMA;

EID: 85049974896     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.312494     Document Type: Article

References (31)

1. Libby P. Mechanisms of acute coronary syndromes. N Engl J Med. 2013;369:883-884. doi: 10.1056/NEJMc1307806.
2. Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114:1852-1866. doi: 10.1161/CIRCRESAHA.114.302721.
3. Pasterkamp G, den Ruijter HM, Libby P. Temporal shifts in clinical pre-sentation and underlying mechanisms of atherosclerotic disease. Nat Rev Cardiol. 2017;14:21-29. doi: 10.1038/nrcardio.2016.166.
4. Quillard T, Franck G, Mawson T, Folco E, Libby P. Mechanisms of ero-sion of atherosclerotic plaques. Curr Opin Lipidol. 2017;28:434-441. doi: 10.1097/MOL.0000000000000440.
5. Campbell IC, Suever JD, Timmins LH, Veneziani A, Vito RP, Virmani R, Oshinski JN, Taylor WR. Biomechanics and infammation in atherosclerotic plaque erosion and plaque rupture: implications for car-diovascular events in women. PLoS One. 2014;9:e111785. doi: 10.1371/journal.pone.0111785.
6. Jia H, Abtahian F, Aguirre AD, et al. In vivo diagnosis of plaque erosion and calcifed nodule in patients with acute coronary syndrome by intravas-cular optical coherence tomography. J Am Coll Cardiol. 2013;62:1748-1758. doi: 10.1016/j.jacc.2013.05.071.
7. Döring Y, Drechsler M, Wantha S, Kemmerich K, Lievens D, Vijayan S, Gallo RL, Weber C, Soehnlein O. Lack of neutrophil-derived CRAMP reduces atherosclerosis in mice. Circ Res. 2012;110:1052-1056. doi: 10.1161/CIRCRESAHA.112.265868.
8. Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res. 2012;110:875-888. doi: 10.1161/CIRCRESAHA.111.257535.
9. Simon DI, Zidar D. Neutrophils in atherosclerosis: alarmin evidence of a hit and run? Circ Res. 2012;110:1036-1038. doi: 10.1161/CIRCRESAHA.112.268367.
10. Yamashiro S, Kamohara H, Wang JM, Yang D, Gong WH, Yoshimura T. Phenotypic and functional change of cytokine-activated neutrophils: in-fammatory neutrophils are heterogeneous and enhance adaptive immune responses. J Leukoc Biol. 2001;69:698-704.
11. Galligan C, Yoshimura T. Phenotypic and functional changes of cytokine-activated neutrophils. Chem Immunol Allergy. 2003;83:24-44.
12. Quillard T, Araújo HA, Franck G, Shvartz E, Sukhova G, Libby P. TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superfcial erosion. Eur Heart J. 2015;36:1394-1404. doi: 10.1093/eurheartj/ehv044.
13. Franck G, Mawson T, Sausen G, et al. Flow perturbation mediates neu-trophil recruitment and potentiates endothelial injury via TLR2 in mice: implications for superfcial erosion. Circ Res. 2017;121:31-42. doi: 10.1161/CIRCRESAHA.117.310694.
14. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science. 2004;303:1532-1535. doi: 10.1126/science.1092385.
15. Brill A, Fuchs TA, Savchenko AS, Thomas GM, Martinod K, De Meyer SF, Bhandari AA, Wagner DD. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost. 2012;10:136-144. doi: 10.1111/j.1538-7836.2011.04544.x.
16. Stakos DA, Kambas K, Konstantinidis T, Mitroulis I, Apostolidou E, Arelaki S, Tsironidou V, Giatromanolaki A, Skendros P, Konstantinides S, Ritis K. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction. Eur Heart J. 2015;36:1405-1414. doi: 10.1093/eurheartj/ehv007.
17. Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS, Gallant M, Martinod K, Ten Cate H, Hofstra L, Crijns HJ, Wagner DD, Kietselaer BLJH. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol. 2013;33:2032-2040. doi: 10.1161/ATVBAHA.113.301627.
18. Lande R, Ganguly D, Facchinetti V, et al. Neutrophils activate plas-macytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med. 2011;3:73ra19. doi: 10.1126/scitranslmed.3001180.
19. Warnatsch A, Ioannou M, Wang Q, Papayannopoulos V. Infammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science. 2015;349:316-320. doi: 10.1126/science.aaa8064.
20. Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. 2010;207:1853-1862. doi: 10.1084/jem.20100239.
21. Knight JS, Luo W, O'Dell AA, Yalavarthi S, Zhao W, Subramanian V, Guo C, Grenn RC, Thompson PR, Eitzman DT, Kaplan MJ. Peptidylarginine deiminase inhibition reduces vascular damage and modulates in nate immune responses in murine models of atherosclerosis. Circ Res. 2014;114:947-956. doi: 10.1161/CIRCRESAHA.114.303312.
22. Najmeh S, Cools-Lartigue J, Giannias B, Spicer J, Ferri LE. Simplifed human neutrophil extracellular traps (NETs) isolation and handling. J Vis Exp. 2015;98:52687.
23. Park B, Yim JH, Lee HK, Kim BO, Pyo S. Ramalin inhibits VCAM-1 expression and adhesion of monocyte to vascular smooth muscle cells through MAPK and PADI4-dependent NF-kB and AP-1 pathways. Biosci Biotechnol Biochem. 2015;79:539-552. doi: 10.1080/09168451.2014.991681.
24. Nakashima K, Arai S, Suzuki A, Nariai Y, Urano T, Nakayama M, Ohara O, Yamamura K, Yamamoto K, Miyazaki T. PAD4 regulates proliferation of multipotent haematopoietic cells by controlling c-myc expression. Nat Commun. 2013;4:1836. doi: 10.1038/ncomms2862.
25. Goldmann O, Medina E. The expanding world of extracellular traps: not only neutrophils but much more. Front Immunol. 2012;3:420. doi: 10.3389/fmmu.2012.00420.
26. Mogayzel PJ Jr, Naureckas ET, Robinson KA, Mueller G, Hadjiliadis D, Hoag JB, Lubsch L, Hazle L, Sabadosa K, Marshall B; Pulmonary Clinical Practice Guidelines Committee. Cystic fbrosis pulmonary guidelines. Chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2013;187:680-689.
27. Crea F, Libby P. Acute coronary syndromes: the way forward from mechanisms to precision treatment. Circulation. 2017;136:1155-1166. doi: 10.1161/CIRCULATIONAHA.117.029870.
28. Jia H, Dai J, Hou J, Xing L, Ma L, Liu H, Xu M, Yao Y, Hu S, Yamamoto E, Lee H, Zhang S, Yu B, Jang IK. Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion (the EROSION study). Eur Heart J. 2017;38:792-800. doi: 10.1093/eurheartj/ehw381.
29. Wang H, Wang C, Zhao MH, Chen M. Neutrophil extracellular traps can activate alternative complement pathways. Clin Exp Immunol. 2015;181:518-527. doi: 10.1111/cei.12654.
30. Schreiber A, Rousselle A, Becker JU, von Mässenhausen A, Linkermann A, Kettritz R. Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis. Proc Natl Acad Sci USA. 2017;114:E9618-E9625. doi: 10.1073/pnas.1708247114.
31. Jayne DRW, Bruchfeld AN, Harper L, Schaier M, Venning MC, Hamilton P, Burst V, Grundmann F, Jadoul M, Szombati I, Tesar V, Segelmark M, Potarca A, Schall TJ, Bekker P; CLEAR Study Group. Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol. 2017;28:2756-2767. doi: 10.1681/ASN.2016111179.